Maintain a healthy diet and exercise routine to support overall pain management
Mild soreness or redness at the site is normal
If you take your injection or eat too close to bedtime, that fullness or mild nausea can keep you uncomfortable and wide awake
Key safety monitoring parameters include: Baseline and periodic assessment of nutritional status (complete blood count, comprehensive metabolic panel, vitamin levels, albumin) Renal function monitoring, particularly during dose escalation, due to risk of acute kidney injury from dehydration Evaluation for gastrointestinal symptoms and differentiation from surgical complications Monitoring for gallbladder disease, which may be increased with weight loss and semaglutide use Assessment of medication adherence and injection technique Eye examination in patients with diabetes due to potential risk of diabetic retinopathy progression with rapid glycemic improvement Regular follow-up with both bariatric surgery and endocrinology or obesity medicine teams when possible Patients should be counseled to report severe or persistent nausea, vomiting, abdominal pain, or inability to maintain adequate hydration or nutrition, as these may warrant dose adjustment, temporary discontinuation, or further evaluation for surgical complications
Sometimes GLP-1s that are approved for type 2 diabetes can be prescribed off-label for weight loss
Have you ever considered how much of your overall health is tied directly to the condition of your gut
